சாம் ல்யாநியந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from சாம் ல்யாநியந். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In சாம் ல்யாநியந் Today - Breaking & Trending Today
Dr Boreham's Crucible: Can Lumos (ASX:LDX) light up the US with FDA approval? stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.
Rory Hunter, portfolio manager, said Australian medical technology was among the best in the world and the fund would offer investors access to high quality growth companies. “Australia s history of medical breakthroughs includes penicillin, the bionic ear, ultrasounds, spray-on skin, and the cervical cancer vaccine,” Hunter said. “In addition, there are many research facilities in Australia which are recognised as medical centres of excellence at a global level. “Investors will also benefit from several tailwinds that are driving innovation and growth in medical research and technology.” The fund would be run by the SGH emerging companies team and guided by the SGH medical technology advisory board, which was comprised of: ....
Press release content from Business Wire. The AP news staff was not involved in its creation. Lumos Diagnostics Appoints Three Industry Leaders as Independent Directors May 5, 2021 GMT SARASOTA, Fla. (BUSINESS WIRE) May 5, 2021 Lumos Diagnostics announced today the expansion of its board with the appointment of three new independent directors to support the continued growth of the company’s rapid point-of-care diagnostic products and services business. Bronwyn Le Grice, Lawrence Mehren and Catherine Robson will join Executive Chair Sam Lanyon and and Executive Director Rob Sambursky, MD. “On behalf of the entire company, I am delighted to welcome Bronwyn, Larry and Catherine to the Lumos Board of Directors,” said Sam Lanyon, executive chair of Lumos Diagnostics. “Together, they offer extensive and diverse operational experience in growing diagnostic companies, strong knowledge of equity markets and broad corporate governance expertise. Lumos will benef ....
Australian startups hope Ellume s success will help tap global markets We’re sorry, this service is currently unavailable. Please try again later. Dismiss Australian startups hope Ellume s success will help tap global markets Normal text size Advertisement Australian startups at the cutting edge of rapid diagnostic testing say a decision from US regulators to approve an at-home COVID-19 test from Brisbane biotech Ellume will help unlock global markets for local firms. Ellume made headlines on Wednesday after the company secured emergency use authorisation to sell its over-the-counter tests in the US market. It is the first self-test to be approved for coronavirus in the US market and the business plans to ship more than 20 million units in 2021, having received $US40 million from the US government to develop the technology. ....